4//SEC Filing
Coiante Scott M 4
Accession 0001127602-25-005212
CIK 0001062822other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:17 PM ET
Size
7.8 KB
Accession
0001127602-25-005212
Insider Transaction Report
Form 4
Coiante Scott M
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-13+721,070→ 721,070 totalExercise: $0.69Exp: 2035-02-13→ Common Stock (721,070 underlying) - Award
Restricted Stock Units
2025-02-13+480,710→ 480,710 total→ Common Stock (480,710 underlying)
Footnotes (3)
- [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001608536
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:17 PM ET
- Size
- 7.8 KB